Ing Groep Nv Catalent, Inc. Transaction History

Ing Groep Nv

$16.5 Billion
Q3 2024

A detailed history of Ing Groep Nv transactions in Catalent, Inc. stock. As of the latest transaction made, Ing Groep Nv holds 1,130,504 shares of CTLT stock, worth $66.8 Million. This represents 0.41% of its overall portfolio holdings.

Number of Shares

1,130,504

Previous 430,653 162.51%

Holding current value

$66.8 Million

Previous $24.2 Million 182.78%

% of portfolio

0.41%

Previous 0.15%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	BUY	$56.16 - $60.96 $39.3 Million - $42.7 Million	699,851 Added 162.51%	1,130,504 $68.5 Million
Q2 2024 Aug 13, 2024	SELL	$53.58 - $57.02 $22,182 - $23,606	-414 Reduced 0.1%	430,653 $24.2 Million
Q1 2024 May 10, 2024	SELL	$42.56 - $59.82 $3.04 Million - $4.28 Million	-71,513 Reduced 14.23%	431,067 $24.3 Million
Q4 2023 Feb 08, 2024	BUY	$32.18 - $46.57 $722,376 - $1.05 Million	22,448 Added 4.68%	502,580 $22.6 Million
Q3 2023 Oct 27, 2023	SELL	$44.2 - $50.2 $10.2 Million - $11.6 Million	-230,593 Reduced 32.44%	480,132 $21.9 Million
Q2 2023 Aug 07, 2023	BUY	$31.86 - $67.26 $22.5 Million - $47.4 Million	704,887 Added 12074.12%	710,725 $30.8 Million
Q1 2023 May 09, 2023	BUY	$45.44 - $74.26 $265,278 - $433,529	5,838 New	5,838 $383,000
Q1 2022 May 13, 2022	SELL	$94.19 - $124.49 $2.1 Million - $2.78 Million	-22,343 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$119.57 - $139.07 $961,581 - $1.12 Million	8,042 Added 56.23%	22,343 $2.86 Million
Q3 2021 Nov 02, 2021	BUY	$109.17 - $142.35 $33,951 - $44,270	311 Added 2.22%	14,301 $1.9 Million
Q2 2021 Aug 13, 2021	BUY	$100.34 - $115.69 $272,824 - $314,561	2,719 Added 24.12%	13,990 $1.51 Million
Q1 2021 May 12, 2021	BUY	$101.51 - $125.27 $35,223 - $43,468	347 Added 3.18%	11,271 $1.19 Million
Q4 2020 Feb 11, 2021	BUY	$85.88 - $105.36 $626,151 - $768,179	7,291 Added 200.69%	10,924 $1.14 Million
Q3 2020 Nov 12, 2020	BUY	$72.74 - $92.5 $264,264 - $336,052	3,633 New	3,633 $311,000
Q3 2019 Nov 08, 2019	SELL	$47.45 - $58.05 $438,200 - $536,091	-9,235 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$39.26 - $54.21 $706 - $975	18 Added 0.2%	9,235 $501,000
Q1 2019 May 13, 2019	BUY	$29.84 - $43.92 $984 - $1,449	33 Added 0.36%	9,217 $374,000
Q4 2018 Feb 13, 2019	BUY	$29.95 - $46.34 $275,060 - $425,586	9,184 New	9,184 $286,000
Q2 2018 Aug 10, 2018	SELL	$38.72 - $42.52 $785,202 - $862,263	-20,279 Closed	0 $0
Q1 2018 May 07, 2018	BUY	$39.4 - $47.39 $9,140 - $10,994	232 Added 1.16%	20,279 $833,000
Q4 2017 Feb 06, 2018	BUY	$37.27 - $43.02 $147,589 - $170,359	3,960 Added 24.62%	20,047 $824,000
Q3 2017 Nov 08, 2017	BUY	$33.75 - $41.67 $542,936 - $670,345	16,087	16,087 $642,000

Others Institutions Holding CTLT

# of Institutions

512

Shares Held

149M

Call Options Held

575K

Put Options Held

2.03M

View Full List

About Catalent, Inc.

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $10.6B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

More about CTLT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ing Groep Nv, based on Form 13F filings with the SEC.

News

Stay updated on Ing Groep Nv with notifications on news.

Account